Hervé Ghesquières

20PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyMedical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 10, 2026
Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study.

|Jan 09, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Hervé Ghesquières, Youenn Drouet, Susan L Slager

|Apr 16, 2025
Netrin-1 and B-cell maturation antigen expression in a large cohort of 361 lymphomas: sensitive and specific staining in plasmablastic lymphomas, and therapeutic perspectives.

Marie Donzel, Alexis Trecourt, Hervé Ghesquières

|Dec 01, 2024
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.

Anna Sureda, Antonio Pinto, Hervé Ghesquières

|Oct 01, 2024
Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study.

C Bommier, M Donzel, C Rossi

|Jul 11, 2024
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital.

Caroline Le Lan, Aurélien Belot, Camille Golfier

Pageof 4

Frequent Collaborators

3 joint publications

Lucie Oberic

2 joint publications

David Sibon

2 joint publications

Marie Donzel

2 joint publications

Gilles Salles